These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8135389)

  • 1. Efficacy of methylnaltrexone versus naloxone for reversal of morphine-induced depression of hypoxic ventilatory response.
    Amin HM; Sopchak AM; Foss JF; Esposito BF; Roizen MF; Camporesi EM
    Anesth Analg; 1994 Apr; 78(4):701-5. PubMed ID: 8135389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives.
    Brown DR; Robertson MJ; Goldberg LI
    Neuropharmacology; 1983 Mar; 22(3):317-21. PubMed ID: 6682490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice.
    Walentiny DM; Komla E; Moisa LT; Mustafa MA; Poklis JL; Akbarali HI; Beardsley PM
    Neuropharmacology; 2021 Mar; 185():108437. PubMed ID: 33316279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil.
    Amin HM; Sopchak AM; Esposito BF; Henson LG; Batenhorst RL; Fox AW; Camporesi EM
    J Pharmacol Exp Ther; 1995 Jul; 274(1):34-9. PubMed ID: 7616418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of methylnaltrexone and naloxone on esophageal motor function in man.
    Scarpellini E; Pauwels A; Vos R; Rommel N; Tack J
    Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 28110513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of morphine and methylnaltrexone on gastrointestinal pain in healthy male participants.
    Brokjaer A; Olesen AE; Christrup LL; Dahan A; Drewes AM
    Neurogastroenterol Motil; 2015 May; 27(5):693-704. PubMed ID: 25810023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid-induced delay in gastric emptying: a peripheral mechanism in humans.
    Murphy DB; Sutton JA; Prescott LF; Murphy MB
    Anesthesiology; 1997 Oct; 87(4):765-70. PubMed ID: 9357876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.
    Singleton PA; Moreno-Vinasco L; Sammani S; Wanderling SL; Moss J; Garcia JG
    Am J Respir Cell Mol Biol; 2007 Aug; 37(2):222-31. PubMed ID: 17395891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs.
    Foss JF; Bass AS; Goldberg LI
    J Clin Pharmacol; 1993 Aug; 33(8):747-51. PubMed ID: 8408737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of morphine-induced respiratory depression with nalmefene.
    Konieczko KM; Jones JG; Barrowcliffe MP; Jordan C; Altman DG
    Br J Anaesth; 1988 Sep; 61(3):318-23. PubMed ID: 3140862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the opioid antagonist N-methylnaltrexone and evaluation of its effects on gastrointestinal tract function in horses treated or not treated with morphine.
    Boscan P; Van Hoogmoed LM; Pypendop BH; Farver TB; Snyder JR
    Am J Vet Res; 2006 Jun; 67(6):998-1004. PubMed ID: 16740093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial.
    Yuan CS; Wei G; Foss JF; O'Connor M; Karrison T; Osinski J
    J Pharmacol Exp Ther; 2002 Jan; 300(1):118-23. PubMed ID: 11752106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
    Yuan CS; Foss JF; O'Connor M; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1996 Apr; 59(4):469-75. PubMed ID: 8612393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone improves arterial blood pressure and hypoxic ventilatory depression, but not survival, of rats during acute hypoxia.
    Endoh H; Honda T; Ohashi S; Shimoji K
    Crit Care Med; 2001 Mar; 29(3):623-7. PubMed ID: 11373431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of potency and duration of action of nalmefene and naloxone.
    Glass PS; Jhaveri RM; Smith LR
    Anesth Analg; 1994 Mar; 78(3):536-41. PubMed ID: 8109774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; Osinski J; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1997 Apr; 61(4):467-75. PubMed ID: 9129564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.
    Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G
    Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists.
    Russell J; Bass P; Goldberg LI; Schuster CR; Merz H
    Eur J Pharmacol; 1982 Mar; 78(3):255-61. PubMed ID: 7200037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No effect of naloxone on hypoxia-induced ventilatory depression in adults.
    Kagawa S; Stafford MJ; Waggener TB; Severinghaus JW
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Apr; 52(4):1030-4. PubMed ID: 7085403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.